Taysha Gene Therapies Inc (NAS:TSHA)
$ 2.16 -0.1 (-4.42%) Market Cap: 434.98 Mil Enterprise Value: 391.84 Mil PE Ratio: 0 PB Ratio: 7.45 GF Score: 29/100

Taysha Gene Therapies Inc (TSHA) Transcripts

  • 1